Specialty Compounding for Improved Patient Care: A National Survey of Compounding Pharmacists
Download in electronic PDF format for $75
Abstract: The apparent re-emergence of pharmaceutical compounding as an important part of health care is largely explained by the increasing demand for pharmaceutical preparations that are not commercially available. However, there have been recent discussions among regulatory agencies and various stakeholders of the pharmacy profession as to the safety and efficacy of pharmaceutical compounding, and how compounding should best be regulated. In light of this discussion, the American College of Apothecaries conducted a survey of International Journal of Pharmaceutical Compounding subscribers in July 2005 to (1) assess the safety and efficacy of compounded preparations, (2) describe the types of compounding and other professional services that are offered by pharmacists, and (3) describe selected compounding pharmacies. In general, respondents reported few incidents of adverse events resulting from compounded preparations, and reported having offered a variety of compounding, professional, and patient care specialties se
Related Keywords:
American College of Apothecaries, pharmacist survey, compounding services, regulation, US Food and Drug Administration, accreditation standards, Pharmacy Compounding Accreditation Board, United States Pharmacopeia, specialty, adverse effects, revenue
| Related Articles from IJPC |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
Specialty Compounding for Improved Patient Care: 2006 National Survey of Compounding Pharmacists
Huffman DC, Holmes Erin R
|
Jan/Feb 2008
Pg. 74-82
|
Specialty Compounding for Improved Patient Care: A National Survey of Compounding Pharmacists
Huffman DC, Holmes Erin R
|
Nov/Dec 2006
Pg. 462-468
|
Compounding in the Pharmacy Curriculum: Beyond the Basics
Hinkle Amanda R, Newton Gail D
|
May/Jun 2004
Pg. 181-185
|
Patient-centered Care as Value-added Service by Compounding Pharmacists
McPherson Timothy B, Fontane Patrick E, Day Jonathan R
|
Jul/Aug 2013
Pg. 339-343
|
The U.S. Food and Drug Administration Responds to the International Academy of Compounding Pharmacists' Outsourcing Letter
Miller David G
|
May/Jun 2014
Pg. 208
|
Certification, Accreditation, and Credentialing for 503A Compounding Pharmacies
Pritchett Jon, McCrory Gary, Kraemer Cheri, Jensen Brenda, Allen Loyd V Jr
|
Jan/Feb 2018
Pg. 7-16
|
U.S. Food and Drug Administration Inspections: Guide to a Successful Outcome for 503A Sterile Compounding Pharmacies
Yoch Doug
|
Mar/Apr 2017
Pg. 95-102
|
Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines
Allen Loyd V Jr
|
Jul/Aug 2016
Pg. 351
View Sample |
U.S. Food and Drug Administration Proposed Guidance Document: Compounding Animal Drugs from Bulk Substances
Miller David G
|
Jul/Aug 2015
Pg. 303-305
|
U.S. Food and Drug Administration "Evaluation Criteria" for Difficult to Compound Drugs
Allen Loyd V Jr
|
Nov/Dec 2015
Pg. 487-488
|
PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs
Allen Loyd V Jr
|
Sep/Oct 2017
Pg. 356
|
PreScription: American Pharmacists Assocation and Compounding: New Partnership Reflects Old Ties
Menighan Thomas E
|
Jan/Feb 2010
Pg. 4
|
Pharmacists' Perceptions of the Economic Value of Compounded Pharmaceuticals: A Comparison of Compounded and Commercial Pharmaceuticals in Select Disease States
Lobb William B, Wilkin Noel E, Holmes Erin R
|
Nov/Dec 2015
Pg. 514-520
|
The Role of Compounding in Closing Therapeutic Gaps--Abstracts from FIP 2013
Lutz Eugene, Pauletti Giovanni, Carvalho Maria, Davidson Gigi, Ashworth Lisa, Subramaniam Vaiyapuri, Llambí Francesc
|
Jan/Feb 2014
Pg. 6-12
|
Pharmaceutical Compounding: The Oldest, Most Symbolic, and Still Vital Part of Pharmacy
Kochanowska-Karamyan Anna J
|
Sep/Oct 2016
Pg. 367-374
|
Current Topical Treatments in Wound Healing - Part 1
Helmke Christopher D
|
Jul/Aug 2004
Pg. 269-274
|
Pharmacies on the Frontline: Responding to the COVID-19 Pandemic
McElhiney Linda F
|
Jul/Aug 2020
Pg. 287-295
|
Finally: A Final U.S. Food and Drug Administration Memorandum of Understanding, but It's Flawed
Brunner Scott
|
Jul/Aug 2020
Pg. 296-297
|
The International Academy of Compounding Pharmacists Comments to the Draft Memorandum of Understanding
Miller David G
|
Sep/Oct 2015
Pg. 375
|
PostScription: Accreditation by the Pharmacy Compounding Accreditation Board: Raising the Bar for Patient Care
Murry Tom
|
Mar/Apr 2008
Pg. 174-175
|
| Return to Top |
